Join to access to all OVN content. Join for Free
 Season 2, Episode 5: Embracing Opportunity with Tonia Nesheiwat

Season 2, Episode 5: Embracing Opportunity with Tonia Nesheiwat


Share This Article


In this episode of the Pharmaverse podcast, our host Michael Pietrack interviews Tonia Nesheiwat, VP of Medical Affairs at Caribou Biosciences. Covering everything from baseball teams, inspiring family journey to America, and of course the latest in the Pharmaverse. Together, they delve into Tonia's leadership style shaped by sports and family values. Tonia shares insights on the importance of mentorship, the challenges in medical affairs, and advice for aspiring leaders in the pharmaceutical industry. "I want to coach them through it." Tonia stresses the importance of working through issues, and keeping the eye on the ball. The conversation highlights the significance of hard work, the human element in leadership, and the need for continuous personal and professional growth. All the while, with a patients first mindset! Tune in for another great episode.

Be sure to subscribe!

Key Moments:

👨‍👩‍👦 Leadership traits are often instilled early in life.

👩‍🏭 Family sacrifices can shape one's work ethic and values. 

⚾ Sports can provide foundational leadership skills.

📈 Competition should be with oneself, not others.

🤝Mentorship is crucial for personal and professional growth.

📲 Effective communication is key in medical affairs.

💌 Embrace opportunities outside of your comfort zone.

📚 Education is a lifelong journey.

💉 The pharmaceutical industry is competitive but offers niches .

💕Leaders should focus on the human element of their teams. 

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved
OVN Avatar Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved

Explore OVN